PATENT CLAIM ANALYSIS

Application Number: 16097506
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "338000"]

Abstract:
The present invention relates to crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide, to processes for their preparation, to pharmaceutical compositions comprising them and to their use in the control of disorders.

Claim (Index 10):
The pharmaceutical composition of  claim 8  comprising of the hydrate of the compound of the formula (I) in more than 85 percent by weight related to the total amount of all forms of the compound of the formula (I) present in the composition.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 97.0
- Lexical Diversity: 1.30556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16097463', '16097065', '15529996', '15106073', '13856666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256841925026675
- 35 USC 102 Novelty (BERT): 0.5220479362403863
- Combined Prediction Score: 0.7053205668764394
- Mean Citation Score: 266.679436
- Max Citation Score: 294.3370700000001
- Similarity Product: 169.47930292704945

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test